title: Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma.
authors.affiliation: Department of Medical Oncology, National Cancer Institute, Aviano (PN), Italy. mberretta@cro.it.
authors.forename: M
authors.initials: M
authors.lastname: Berretta
authors.forename: R
authors.initials: R
authors.lastname: Di Francia
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017115:Catheter Ablation; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib